Literature DB >> 875822

Rebound hypertension after sudden discontinuation of methyldopa therapy.

D B Frewin, R K Penhall.   

Abstract

A case of "rebound hypertension" resulting from the sudden cessation of methyldopa (Aldomet) therapy is described. The importance of educating patients about the possible outcome of abruptly withdrawing antihypertensive medication is emphasized.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 875822     DOI: 10.5694/j.1326-5377.1977.tb130994.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  4 in total

Review 1.  Risks versus benefits of withdrawing antihypertensive therapy.

Authors:  H P Schobel; R E Schmieder; F H Messerli
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

2.  Clonidine withdrawal-fact or fiction?

Authors:  M C Houston
Journal:  West J Med       Date:  1979-11

Review 3.  Drug withdrawal syndromes-- a literature review.

Authors:  G C Hodding; M Jann; I P Ackerman
Journal:  West J Med       Date:  1980-11

4.  Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension.

Authors:  A J Bune; J P Chalmers; J R Graham; P R Howe; M J West; L M Wing
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.